Viner, Coby http://orcid.org/0000-0001-8097-6991
Ishak, Charles A. http://orcid.org/0000-0002-2287-6738
Johnson, James
Walker, Nicolas J. http://orcid.org/0000-0002-0498-4356
Shi, Hui http://orcid.org/0000-0001-9126-4607
Sjöberg-Herrera, Marcela K. http://orcid.org/0000-0001-7173-048X
Shen, Shu Yi http://orcid.org/0000-0001-7036-2291
Lardo, Santana M. http://orcid.org/0000-0003-0403-5326
Adams, David J. http://orcid.org/0000-0001-9490-0306
Ferguson-Smith, Anne C. http://orcid.org/0000-0002-7608-5894
De Carvalho, Daniel D. http://orcid.org/0000-0002-8572-5259
Hainer, Sarah J. http://orcid.org/0000-0003-0503-1183
Bailey, Timothy L. http://orcid.org/0000-0002-7018-9342
Hoffman, Michael M. http://orcid.org/0000-0002-4517-1562
Funding for this research was provided by:
Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-03948)
Canadian Institutes of Health Research (201512MSH-360970)
Ministry of Training, Colleges and Universities
Canadian Cancer Society (703827)
Ontario Ministry of Research and Innovation (ER-15-11-223)
Ontario Institute for Cancer Research (CSC-FR-UHN)
Temerty Faculty of Medicine, University of Toronto (MC-2015-16)
Princess Margaret Cancer Foundation
Agencia Nacional de Investigación y Desarrollo (1171004)
BLUEPRINT Project (HEALTH-F5-2011-282510)
Wellcome Trust (WT095606RR)
Medical Research Council (MR/J001597/1)
National Institute of General Medical Sciences (R35GM133732, R01GM103544)
Article History
Received: 8 March 2023
Accepted: 21 September 2023
First Online: 8 January 2024
Change Date: 31 January 2024
Change Type: Update
Change Details: The Twitter/X handles have been corrected.
Declarations
:
: Not applicable.
: Not applicable.
: N.J.W. is an inventor on patent applications for technologies that measure and analyze DNA modifications, filed by Cambridge Epigenetix Ltd., for which he also holds stock options. S.Y.S., D.D.De C., and M.M.H. are inventors on patent applications related to cell-free DNA methylation analysis technologies, licensed to Adela. S.Y.S. and D.D.De C. serve in leadership roles at Adela, and own equity in Adela.